Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Cardiology · Non-Obstructive Coronary Artery Disease

Understanding Your Diagnosis: NOCAD, INOCA, and MINOCA

At a Glance

A clear angiogram rules out a major blockage, but not every heart problem. NOCAD, INOCA, and MINOCA can involve small blood-vessel problems, artery spasm, or hidden heart injury, so additional testing helps find the cause, guide treatment, and assess future risk.

If you have been rushed to the hospital with chest pain or signs of a heart attack, only to be told your coronary arteries are “clear” or “normal” after an angiogram, the experience can be deeply confusing and even isolating. You may feel as though your symptoms are being dismissed or that the pain is “all in your head.” However, a “clear” angiogram does not always mean a perfectly healthy heart [1]. It simply means the large arteries on the surface of your heart do not have the typical, major blockages that doctors usually look for.

For a significant number of people, the cause of heart symptoms lies in the smaller vessels or the way the arteries function, rather than a single large blockage [2][3]. Understanding the specific terminology used to describe these “non-obstructive” conditions is the first step toward getting the right treatment and validating your experience.

Defining Your Diagnosis

When an angiogram shows less than 50% blockage in the coronary arteries, doctors use specific terms to categorize what is happening. These are not just labels; they describe different ways the heart can struggle even without major “plumbing” issues.

  • NOCAD (Non-Obstructive Coronary Artery Disease): This is a general anatomical term for when an angiogram or CT scan shows some buildup (plaque) in the arteries, but it blocks less than 50% of the vessel’s diameter [1]. It is an anatomical description, not proof of ischemia.
  • ANOCA (Angina with Non-Obstructive Coronary Arteries): Angina without obstructive disease.
  • INOCA (Ischemia with Non-Obstructive Coronary Arteries): This refers to a situation where the heart muscle is objectively not getting enough oxygen (ischemia), causing symptoms like chest pain (angina), even though the large arteries are not blocked [1][4].
  • MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries): This is a “working diagnosis” used when you have actually had a heart attack—proven by a rise and/or fall in cardiac troponin with at least one value above the 99th percentile, plus clinical evidence of ischemia, combined with less than 50% stenosis and no alternative explanation identified at that stage [5]. It requires further investigation to find the true underlying cause.

Why “Clear” Isn’t Always Fine

For decades, the medical community viewed non-obstructive disease as “benign” or low-risk. We now know this is a myth [6]. Research shows that INOCA and MINOCA carry a real risk of future heart events, including recurrent heart attacks and hospitalizations [7][8].

Risk depends heavily on your specific diagnosis and other health factors. In one registry, a specific cohort of patients with coronary microvascular dysfunction had a 21.3% risk of a major heart event over five years [7]. For those with MINOCA, registries report the risk of a major event within 12 to 17 months can be 10% to 18%, depending on age and ventricular function [9][10]. It is important to note that these figures are not a personal prognosis for every individual reader, but averages from specific study populations. Your symptoms are a signal that your heart is under stress, and they deserve a thorough investigation.

Sex and Gender Differences

If you are a woman, you are statistically more likely to be diagnosed with one of these conditions. While men are more prone to large, obstructive blockages, one study reported that up to 65% of women undergoing angiography for stable chest pain are found to have non-obstructive arteries, compared to about 30% of men [2]. This is often due to differences in how heart disease develops, particularly involving the “micro-vessels” [11]. Importantly, women and men can both have any of these conditions, and a clear angiogram should prompt further testing regardless of gender.

Moving Beyond the Angiogram

Because a standard angiogram only looks at the “big pipes,” your care team should use additional tools to find out what is actually causing your pain. Current guidelines recommend a “multimodality” approach—meaning they use several types of tests to see the whole picture [12][13].

Essential Follow-Up Tests

Test What It Looks For Why It Matters
Cardiac MRI (CMR) Tissue damage, swelling, or scarring. Can distinguish a true heart attack from “mimics” like myocarditis (inflammation) or Takotsubo syndrome (“broken heart syndrome”) [12][14].
Invasive Functional Testing Pressure and flow in the small vessels. Measures Coronary Flow Reserve (CFR) and resistance to see if the tiny vessels are the problem [15][16].
Vasoreactivity Testing How the arteries react to specific triggers. Uses a medication called acetylcholine to see if your arteries “spasm” or constrict inappropriately [17][18].
Intracoronary Imaging (OCT/IVUS) High-resolution “inside” views of the artery wall. Can find tiny tears (SCAD) or “plaque ruptures” that a regular angiogram might miss [19][20].

Is It “In My Head”?

No. If you have been told your arteries are clear but you still feel pain, you are experiencing a documented physiological phenomenon. The pain of INOCA and MINOCA is just as real, and often just as severe, as the pain caused by a major blockage. Standard care now recognizes that these conditions require personalized, “endotype-guided” treatment—meaning your medications should be chosen based on the specific way your heart is misbehaving, whether it is a vessel spasm, a micro-vessel issue, or a tiny tear [21][22].

If your current care team is not looking beyond the “clear” angiogram, it may be time to seek a specialist or a heart center experienced in managing non-obstructive coronary disease. Your diagnosis is the first step toward a treatment plan that addresses the actual cause of your symptoms.

Common questions in this guide

What does NOCAD mean if my angiogram says my arteries are clear?
NOCAD means an angiogram or CT scan shows some plaque, but no major blockage; the narrowing is less than 50%. It does not mean the arteries or blood flow are completely normal, and it does not by itself show whether the heart is receiving enough oxygen.
Can I have real chest pain or a heart attack with no major blockage?
Yes. INOCA can cause reduced blood flow and angina because of problems in the heart's small vessels or artery spasms, while MINOCA is a working diagnosis for a heart attack with less than 50% narrowing and no other explanation found at first. Further testing is needed to identify the cause.
What is the difference between ANOCA, INOCA, NOCAD, and MINOCA?
NOCAD describes plaque in a coronary artery that narrows it by less than 50%, but it does not prove that the heart is short of oxygen. ANOCA means heart-related chest pain without a major blockage, while INOCA means reduced oxygen delivery to the heart without a major blockage. MINOCA means a heart attack has occurred despite less than 50% narrowing, with no alternative cause identified initially.
What tests can find the cause after a clear coronary angiogram?
A cardiac MRI can look for heart-muscle damage, inflammation, scarring, or conditions that mimic a heart attack. Invasive functional testing can measure small-vessel blood flow and resistance, acetylcholine testing can look for artery spasm, and OCT or IVUS can reveal small tears or plaque changes missed on a standard angiogram.
Does non-obstructive coronary disease increase my risk of future heart problems?
It can. INOCA and MINOCA are not automatically harmless and have been linked with repeat heart events and hospitalizations, but risk varies with the exact cause, age, heart function, and other health factors. Study averages cannot predict one person's outcome.
How is treatment chosen when the angiogram shows no major blockage?
Treatment is tailored to the mechanism causing symptoms, such as small-vessel dysfunction, artery spasm, or a small arterial tear. Your cardiology team may use additional test results to choose appropriate medications and a follow-up plan.
Does a clear angiogram mean my chest pain is psychological?
No. Chest pain from INOCA or MINOCA can result from measurable changes in blood flow, vessel function, or heart tissue and is a real physical symptom. If the cause remains unclear, ask whether you need additional testing or assessment by a specialist experienced in non-obstructive coronary disease.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my angiogram, do I have completely normal arteries or non-obstructive plaque (1–49% stenosis)?
  2. 2.If my arteries are 'clear,' what specific tests (like CMR or invasive functional testing) will you use to determine the cause of my chest pain or heart attack?
  3. 3.Is my condition considered INOCA or MINOCA, and how does this diagnosis change my risk for future heart events?
  4. 4.Can we perform a Cardiac MRI (CMR) to check for conditions that mimic a heart attack, such as myocarditis or Takotsubo syndrome?
  5. 5.What are the specific results of my Coronary Flow Reserve (CFR) or Index of Microvascular Resistance (IMR) if functional testing was done?
  6. 6.Are my current medications targeting the specific mechanism of my chest pain (e.g., vasospasm vs. microvascular dysfunction)?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Coronary functional assessment in non-obstructive coronary artery disease: Present situation and future direction.

    Zhai C, Fan H, Zhu Y, et al.

    Frontiers in cardiovascular medicine 2022; (9()):934279 doi:10.3389/fcvm.2022.934279.

    PMID: 36082113
  2. 2

    A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA).

    Bastiany A, Pacheco C, Sedlak T, et al.

    CJC open 2022; (4(8)):709-720 doi:10.1016/j.cjco.2022.04.009.

    PMID: 36035733
  3. 3

    Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis.

    Mileva N, Nagumo S, Mizukami T, et al.

    Journal of the American Heart Association 2022; (11(7)):e023207 doi:10.1161/JAHA.121.023207.

    PMID: 35301851
  4. 4

    Phenotype-based management of coronary microvascular dysfunction.

    Ang DTY, Berry C, Kaski JC

    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2022; (29(6)):3332-3340 doi:10.1007/s12350-022-03000-w.

    PMID: 35672569
  5. 5

    Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA).

    Occhipinti G, Bucciarelli-Ducci C, Capodanno D

    European heart journal. Acute cardiovascular care 2021; (10(7)):813-822 doi:10.1093/ehjacc/zuab049.

    PMID: 34179954
  6. 6

    An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.

    Kunadian V, Chieffo A, Camici PG, et al.

    European heart journal 2020; (41(37)):3504-3520 doi:10.1093/eurheartj/ehaa503.

    PMID: 32626906
  7. 7

    Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.

    Lee SH, Shin D, Lee JM, et al.

    Journal of the American Heart Association 2022; (11(9)):e025171 doi:10.1161/JAHA.121.025171.

    PMID: 35475358
  8. 8

    Long-term outcomes of ischaemia with no obstructive coronary artery disease (INOCA): a systematic review and meta-analysis.

    Odanović N, Schwann AN, Zhang Z, et al.

    Open heart 2024; (11(2)) doi:10.1136/openhrt-2024-002852.

    PMID: 39353703
  9. 9

    Clinical characteristics and prognosis of myocardial infarction with non-obstructive coronary arteries: A prospective single-center study.

    Lopez-Pais J, Izquierdo Coronel B, Galán Gil D, et al.

    Cardiology journal 2022; (29(5)):798-806 doi:10.5603/CJ.a2020.0146.

    PMID: 33140385
  10. 10

    Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.

    Dreyer RP, Tavella R, Curtis JP, et al.

    European heart journal 2020; (41(7)):870-878 doi:10.1093/eurheartj/ehz403.

    PMID: 31222249
  11. 11

    Coronary Microvascular Dysfunction and Estrogen Receptor Signaling.

    Tunc E, Eve AA, Madak-Erdogan Z

    Trends in endocrinology and metabolism: TEM 2020; (31(3)):228-238 doi:10.1016/j.tem.2019.11.001.

    PMID: 31787492
  12. 12

    Diagnostic Value of Cardiac Magnetic Resonance Imaging and Intracoronary Optical Coherence Tomography in Patients With a Working Diagnosis of Myocardial Infarction With Non-obstructive Coronary Arteries - A Systematic Review and Meta-analysis.

    Machanahalli Balakrishna A, Ismayl M, Thandra A, et al.

    Current problems in cardiology 2023; (48(6)):101126 doi:10.1016/j.cpcardiol.2022.101126.

    PMID: 35120967
  13. 13

    Diagnostic approach in patients with angina and no obstructive coronary artery disease: emphasising the role of the coronary function test.

    Konst RE, Damman P, Pellegrini D, et al.

    Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2021; (29(3)):121-128 doi:10.1007/s12471-020-01532-9.

    PMID: 33415605
  14. 14

    Clinical impact of cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries: a prospective multicentre cohort study.

    Rajwani A, Giudicatti L, Telyuk P, et al.

    Heart (British Cardiac Society) 2025; (112(2)):95-102 doi:10.1136/heartjnl-2024-325181.

    PMID: 40514208
  15. 15

    Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study.

    Corcoran D, Young R, Adlam D, et al.

    International journal of cardiology 2018; (266()):7-14 doi:10.1016/j.ijcard.2018.04.061.

    PMID: 29716756
  16. 16

    Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and Adenosine-Mediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries.

    Feenstra RGT, Boerhout CKM, Woudstra J, et al.

    Circulation. Cardiovascular interventions 2022; (15(8)):e012017 doi:10.1161/CIRCINTERVENTIONS.122.012017.

    PMID: 35904014
  17. 17

    Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery disease.

    Tjoe B, Pacheco C, Suppogu N, et al.

    American heart journal plus : cardiology research and practice 2025; (53()):100527 doi:10.1016/j.ahjo.2025.100527.

    PMID: 40182421
  18. 18

    Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries.

    Montone RA, Rinaldi R, Del Buono MG, et al.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2022; (18(8)):e666-e676 doi:10.4244/EIJ-D-21-00971.

    PMID: 35377315
  19. 19

    Pathological findings at invasive assessment in MINOCA: a systematic review and meta-analysis.

    Fedele D, Cavallo D, Bodega F, et al.

    Heart (British Cardiac Society) 2025; (111(7)):291-299 doi:10.1136/heartjnl-2024-324565.

    PMID: 39689931
  20. 20

    Role of Intracoronary Imaging in Myocardial Infarction with Non-Obstructive Coronary Disease (MINOCA): A Review.

    Borzillo I, De Filippo O, Manai R, et al.

    Journal of clinical medicine 2023; (12(6)) doi:10.3390/jcm12062129.

    PMID: 36983131
  21. 21

    Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial.

    Ford TJ, Stanley B, Good R, et al.

    Journal of the American College of Cardiology 2018; (72(23 Pt A)):2841-2855 doi:10.1016/j.jacc.2018.09.006.

    PMID: 30266608
  22. 22

    Functional coronary vascular disease: endotype-based classification, diagnosis, and targeted management.

    El Khatib O, Al Azzoni A, Shantouf R, Atallah B

    Frontiers in cardiovascular medicine 2026; (13()):1811419 doi:10.3389/fcvm.2026.1811419.

    PMID: 42548607

This page is for informational purposes only and does not constitute medical advice or diagnose the cause of your symptoms. Discuss your angiogram and testing with a cardiologist, and seek urgent care for new or severe chest pain.

Get notified when new evidence is published on nonobstructive coronary artery disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.